Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating BL-M17D1 in locally advanced or metastatic breast cancer (HER2 positive and negative) and other solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Solid Tumors

Drugs mentioned

• BL-M17D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Breast Cancer, Solid Tumor | Phase 1 | Status: RECRUITING